Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HER2-positive Breast Cancer × Biopsy × 1 year × Clear all

Sponsor

Conditions

Neoplasm Metastasis 43 Leukemia, Myeloid, Acute 40 Multiple Myeloma 37 Prostatic Neoplasms 29 Breast Neoplasms 29 Lung Neoplasms 24 Leukemia, Lymphocytic, Chronic, B-Cell 22 Colorectal Neoplasms 22 Lymphoma 20 Myelodysplastic Syndromes 19 Triple Negative Breast Neoplasms 18 Pancreatic Neoplasms 18 Ovarian Neoplasms 18 Lymphoma, Large B-Cell, Diffuse 18 Carcinoma, Non-Small-Cell Lung 17 Melanoma 15 Leukemia, Myelomonocytic, Chronic 13 Fallopian Tube Neoplasms 13 Carcinoma, Renal Cell 13 Burkitt Lymphoma 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Lymphoma, Follicular 12 Neuroblastoma 11 Glioma 11 Sarcoma 10 Neoplasms 10 Myeloproliferative Disorders 10 Lymphoma, Non-Hodgkin 10 Endometrial Neoplasms 9 Stomach Neoplasms 8

Interventions

Trastuzumab 13 pertuzumab 8 Docetaxel 6 tucatinib 5 pyrotinib 4 Capecitabine 4 Paclitaxel 3 Carboplatin 2 Ado-Trastuzumab Emtansine 2 trastuzumab deruxtecan 1 pegfilgrastim 1 neratinib 1 exemestane 1 dalpiciclib 1 Leuprolide 1 Isovaleryl-CoA Dehydrogenase 1 Injections 1 Goserelin 1 Fulvestrant 1 Fluorodeoxyglucose F18 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡